Production and characterization of haploidentical CD19 CAR T cells: Validated to induce a continuous complete remission in a patient with relapsed refractory B-cell ALL.

导出原文传递

翻译打印收藏纠错

第一作者： Somsak,Prasongtanakij

第一单位： Office of Research, Academic Affairs and Innovation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

作者： Somsak,Prasongtanakij ^[1] ; Usanarat,Anurathapan ^[2] ; Thitinee,Vanichapol ^[2] ; Bunyada,Jittorntrum ^[1] ; Korakot,Atjanasuppat ^[2] ; Pongpak,Pongpitcha ^[2] ; Samart,Pakakasama ^[2] ; Duantida,Songdej ^[2] ; Nongnuch,Sirachainan ^[2] ; Karan,Paisooksantivatana ^[3] ; Suparerk,Borwaornpinyo ^[4] ; Borje S,Andersson ^[5] ; Suradej,Hongeng ^[2]

作者单位： Office of Research, Academic Affairs and Innovation, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. ^[1] Department of Pediatrics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. ^[2] Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand. ^[3] Department of Biotechnology, Faculty of Science, Mahidol University, Bangkok, Thailand. ^[4] Department of Stem Cell Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. ^[5]

关键词 CD19 acute lymphoblastic leukemia (ALL)chimeric antigen receptor (CAR) T cells cytotoxicity immunotherapy

主题词抗原, CD19(Antigens, CD19);人类(Humans);免疫疗法, 过继(Immunotherapy, Adoptive);男(雄)性(Male);前体细胞淋巴母细胞白血病淋巴瘤(Precursor Cell Lymphoblastic Leukemia-Lymphoma);缓解诱导(Remission Induction);T淋巴细胞(T-Lymphocytes)

DOI 10.1111/ajco.13474

PMID 32970928

发布时间 2022-02-10

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交